BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22260647)

  • 21. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).
    Jin Y; Tong L; Ai P; Li M; Hou X
    Int J Pharm; 2006 Feb; 309(1-2):199-207. PubMed ID: 16377106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir.
    Yang C; Gao H; Mitra AK
    J Pharm Sci; 2001 May; 90(5):617-24. PubMed ID: 11288106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Water-soluble, solution-stable, and biolabile N-substituted (aminomethyl)benzoate ester prodrugs of acyclovir.
    Bundgaard H; Jensen E; Falch E
    Pharm Res; 1991 Sep; 8(9):1087-93. PubMed ID: 1788153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Water-promoted hydrolysis of a highly twisted amide: rate acceleration caused by the twist of the amide bond.
    Mujika JI; Mercero JM; Lopez X
    J Am Chem Soc; 2005 Mar; 127(12):4445-53. PubMed ID: 15783227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid-catalyzed reactions of twisted amides in water solution: competition between hydration and hydrolysis.
    Wang B; Cao Z
    Chemistry; 2011 Oct; 17(42):11919-29. PubMed ID: 21901771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugation of squalene to acyclovir improves the affinity for biomembrane models.
    Sarpietro MG; Micieli D; Rocco F; Ceruti M; Castelli F
    Int J Pharm; 2009 Dec; 382(1-2):73-9. PubMed ID: 19686827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the nucleobase and anchimeric assistance of the carboxyl acid groups in the hydrolysis of amino acid nucleoside phosphoramidates.
    Maiti M; Michielssens S; Dyubankova N; Maiti M; Lescrinier E; Ceulemans A; Herdewijn P
    Chemistry; 2012 Jan; 18(3):857-68. PubMed ID: 22173724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipeptidyl peptidase IV (DPPIV/CD26)-based prodrugs of hydroxy-containing drugs.
    Diez-Torrubia A; Cabrera S; Lambeir AM; Balzarini J; Camarasa MJ; Velázquez S
    ChemMedChem; 2012 Apr; 7(4):618-28. PubMed ID: 22307932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
    Sun H
    Bioorg Med Chem Lett; 2012 Jan; 22(2):989-95. PubMed ID: 22197392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of hydrolysis of indomethacin and indomethacin ester prodrugs in aqueous solution.
    Kahns AH; Jensen PB; Mørk N; Bundgaard H
    Acta Pharm Nord; 1989; 1(6):327-36. PubMed ID: 2624703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization and stability of dendrimer prodrugs.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Int J Pharm; 2006 Feb; 308(1-2):175-82. PubMed ID: 16384673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir chemical kinetics with the discovery and identification of newly reported degradants and degradation pathways involving formaldehyde as a degradant and reactant intermediate.
    Bejgum BC; Johnson PR; Stagner WC
    Int J Pharm; 2018 Jan; 535(1-2):172-179. PubMed ID: 29061324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
    Zhou Y; Wei YH; Zhang GQ; Wu XA
    Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfenamides as prodrugs of NH-acidic compounds: a new prodrug option for the amide bond.
    Guarino VR; Karunaratne V; Stella VJ
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4910-3. PubMed ID: 17604170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS; Patel J; Mitra AK
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
    Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
    Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis--a computational approach.
    Karaman R; Dokmak G; Bader M; Hallak H; Khamis M; Scrano L; Bufo SA
    J Mol Model; 2013 Jan; 19(1):439-52. PubMed ID: 22940872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New green synthesis and formulations of acyclovir prodrugs.
    de Regil-Hernández R; Martínez-Lagos F; Rodríguez-Bayón A; Sinisterra JV
    Chem Pharm Bull (Tokyo); 2011; 59(9):1089-93. PubMed ID: 21881250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.